Balance Sheet Data
Catalyst Biosciences, Inc. (CBIO)
$0.37
-0.02 (-6.07%)
Year A/P | 2017 Actual | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Projected | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected |
Total Cash | 32.44 | 120.13 | 76.87 | 79.35 | 46.85 | 0.06 | 0 | 0 | 0 | 0 |
---|---|---|---|---|---|---|---|---|---|---|
Total Cash (%) | ||||||||||
Account Receivables | 0.02 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Account Receivables (%) | ||||||||||
Inventories | - | - | - | - | - | - | - | - | - | - |
Inventories (%) | ||||||||||
Accounts Payable | 0.75 | 1.25 | 4.28 | 5.93 | 6.42 | 0.01 | 0 | 0 | 0 | 0 |
Accounts Payable (%) | ||||||||||
Capital Expenditure | -0.02 | -0.38 | -0.06 | -0.27 | -0.84 | -0 | -0 | -0 | -0 | -0 |
Capital Expenditure (%) |
To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows)
and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.